Monash IVF rejects NBIO proposal to acquire MVF
Filed with ASX · · 2 pages · English
Monash IVF Group Limited (ASX : MVF, the “Company” or “Monash IVF”) has received an opportunistic, unsolicited, conditional and non- binding indicative proposal from a consortium comprising Genesis Capital Investment Management Pty Ltd ("Genesis Capital" or "Genesis") and WHSP Holdings Pty Limited ("Soul Patts") (together, the "Consortium" and each a “Consortium Member”) to acquire 100% of the sha
Earlier from Monash IVF
- 2025 AGM - Investor Presentation
- 2025 AGM - Chair Address
- Appointment of Chief Executive Officer and Managing Director
- S&P DJI Announces September 2025 Quarterly Rebalance
- FY25 MVF Results Announcement
Later from Monash IVF
- NBIO withdrawn to acquire Monash IVF
- 1H26 Appendix 4D and Financial Report
- MVF delivers 1H26 Underlying NPAT of $10.4m
- 1H26 Results Presentation
- Revised NBIO to acquire MVF
Follow Monash IVF into a list and get an email when it puts out news.
Follow Monash IVF